Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™
July 12, 2022 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., July 12, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...
Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual Meeting
June 06, 2022 07:05 ET
|
Helius Medical Technologies, Inc.
-- Study finds significant improvement in gait deficit in multiple sclerosis patients using translingual neurostimulation (“PoNS Therapy®”) combined with a therapeutic exercise program -- -- Poster...
Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®
June 01, 2022 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...
Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual Conference
May 31, 2022 08:36 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., May 31, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
May 24, 2022 16:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., May 24, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience Program
May 17, 2022 07:30 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., May 17, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...
Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®
May 12, 2022 06:50 ET
|
Helius Medical Technologies, Inc.
-- Company to host call at 9:00am today with CEO, CFO, CMO and VP Sales & Marketing -- NEWTOWN, Pa., May 12, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius”...
Helius Medical Technologies, Inc. to Release First Quarter 2022 Financial Results on May 12, 2022
May 03, 2022 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., May 03, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS®
April 27, 2022 07:05 ET
|
Helius Medical Technologies, Inc.
-- First patients have purchased PoNS devices to initiate PoNS Therapy ---- Nineteen PoNS device prescriptions have been written in the U.S. since recent commercial launch -- NEWTOWN, Pa., April 27,...
Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking Ability
April 26, 2022 07:05 ET
|
Helius Medical Technologies, Inc.
-- Breakthrough technology for MS patients helps patients with gait deficit -- Portable Neuromodulation Stimulator (PoNS®) is an innovative non-surgical medical device that includes a controller and...